Pular para o conteúdo
Hipertensão pulmonar tromboembólica crônica
ORPHA:70591CID-10 · I26.0CID-11 · BB01.3OMIM 612862DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
heartInício adolescenteHerança Unknown
Também conhecida comoCTEPHHPTEC

A Hipertensão Pulmonar Tromboembólica Crônica (HPTEC) acontece quando coágulos de sangue antigos e organizados (que parecem cicatrizes) permanecem nas artérias dos pulmões, entupindo-as. Isso faz com que os vasos sanguíneos dos pulmões fiquem mais estreitos e rígidos, aumentando a dificuldade para o sangue passar (um problema chamado de resistência vascular pulmonar, RVP). Essa situação leva a um aumento da pressão nos pulmões (hipertensão pulmonar, HP) e, com o tempo, à perda progressiva da força do lado direito do coração (insuficiência cardíaca direita).

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A hipertensão pulmonar tromboembólica crônica (HPTEC) ocorre quando coágulos de sangue endurecidos permanecem nos vasos pulmonares, dificultando a circulação e sobrecarregando o coração. Quem convive com a doença costuma perceber cansaço intenso, falta de ar aos esforços físicos, palpitações e episódios de desmaio. No Brasil, a CONITEC avaliou e recusou a incorporação do medicamento riociguate no SUS, e não há protocolo com medicamentos específicos dispensados na rede pública. Apesar disso, o acompanhamento clínico e estudos sobre procedimentos vasculares continuam em andamento em centros especializados.

📋
Informacoes curadas por IA — podem conter imprecisoes

A Hipertensão Pulmonar Tromboembólica Crônica (HPTEC) acontece quando coágulos de sangue antigos e organizados (que parecem cicatrizes) permanecem nas artérias dos pulmões, entupindo-as. Isso faz com que os vasos sanguíneos dos pulmões fiquem mais estreitos e rígidos, aumentando a dificuldade para o sangue passar (um problema chamado de resistência vascular pulmonar, RVP). Essa situação leva a um aumento da pressão nos pulmões (hipertensão pulmonar, HP) e, com o tempo, à perda progressiva da força do lado direito do coração (insuficiência cardíaca direita).

Pesquisas ativas
30 ensaios
108 total registrados no ClinicalTrials.gov
Publicações científicas
3.747 artigos
Último publicado: 2026 Mar 20
Medicamentos
21 com registro
ATENOLOL, ATENORESE, DIUBLOCK

Tem tratamento?

✓ 21 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
ATENOLOLATENORESEDIUBLOCKATENOPRESSATENOLOL + CLORTALIDONAATEPRESSATENEUMANGIPRESS CD

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, elderly
🏥
SUS: Cobertura parcialScore: 0%
CID-10: I26.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
7 sintomas
🫁
Pulmão
4 sintomas
🩸
Sangue
3 sintomas
🛡️
Imunológico
1 sintomas
😀
Face
1 sintomas
🧠
Neurológico
1 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

90%prev.
Hipertensão arterial pulmonar
Muito frequente (99-80%)
90%prev.
Aumento da resistência vascular pulmonar
Muito frequente (99-80%)
90%prev.
Insuficiência cardíaca congestiva
Muito frequente (99-80%)
55%prev.
Trombose venosa profunda
Frequente (79-30%)
55%prev.
Palpitações
Frequente (79-30%)
55%prev.
Dispneia de esforço
Frequente (79-30%)
37sintomas
Muito frequente (3)
Frequente (7)
Ocasional (23)
Muito raro (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 37 características clínicas mais associadas, ordenadas por frequência.

Hipertensão arterial pulmonarPulmonary arterial hypertension
Muito frequente (99-80%)90%
Aumento da resistência vascular pulmonarIncreased pulmonary vascular resistance
Muito frequente (99-80%)90%
Insuficiência cardíaca congestivaCongestive heart failure
Muito frequente (99-80%)90%
Trombose venosa profundaDeep venous thrombosis
Frequente (79-30%)55%
PalpitaçõesPalpitations
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico3.747PubMed
Últimos 10 anos200publicações
Pico2025108 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado1
3Fase 39
2Fase 27
·Pré-clínico83
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 100 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Hipertensão pulmonar tromboembólica crônica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 22 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

25 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT06286891 · Frailty, Physical Capacity and Lung Function in Postoperativ…Recrutando
🇧🇷 Brasil
NCT07777367 · Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxyg…Recrutando
NA🇨🇭 Suíça
NCT07777445 · Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxyg…Recrutando
NA🇨🇭 Suíça
NCT07855679 · Pulmonary Embolism Registry From Short-Term Emergency to Lon…Recrutando
🇮🇹 Itália · 🇵🇱 Polônia · 🇪🇸 Espanha
NCT07768644 · Nailfold Capillaroscopy in PHRecrutando
🇬🇧 Reino Unido
NCT07522203 · Arterial Wave Energy Flux and Multidimensional Recovery in P…Recrutando
Turkey (Türkiye)
NCT07272798 · Cardiac Self-Efficacy in Patients With Chronic Thromboemboli…Recrutando
Syria
NCT07217522 · Rutgers University Study of the Genetics of Pulmonary Hypert…Recrutando
🇺🇸 Estados Unidos
NCT07254078 · Registry of Patients With chrOnic thromboemboLic Pulmonary h…Recrutando
Russia
NCT06922240 · Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-H…Recrutando
PHASE3🇨🇳 China
NCT06081881 · Chronic Thromboembolic Pulmonary Hypertension After Pulmonar…Recrutando
🇪🇬 Egito
NCT06715280 · Switching of Sildenafil to Riociguat in CTEPH PatientsRecrutando
PHASE4Hong Kong
NCT05110066 · BPA vs. PEA in CTEPHRecrutando
NA🇩🇰 Dinamarca · 🇬🇧 Reino Unido
NCT06038630 · 129Xe MRI CardiopulmonaryRecrutando
PHASE2🇺🇸 Estados Unidos
NCT05843500 · Chronic Thromboembolic Disease RegistryRecrutando
🇺🇸 Estados Unidos
NCT05340023 · Proteomic Pattern Associated With the Diagnosis of Chronic T…Recrutando
🇫🇷 França
NCT06105242 · Biological Sex and CTEPH-related RV Dysfunction and Recovery…Recrutando
🇺🇸 Estados Unidos
NCT04808596 · Pulmonary Hypertension Biorepository and RegistryRecrutando
🇺🇸 Estados Unidos
NCT04206852 · Safety and Efficacy of Balloon Pulmonary Angioplasty in Chin…Recrutando
🇨🇳 China
NCT03959748 · DataBase of pulmoNary hyPertesion in PoLish Population - BNP…Recrutando
🇵🇱 Polônia
NCT05311072 · Change-a Multi-center Chronic Thromboembolic Pulmonary Hyper…Recrutando
🇨🇳 China
NCT04071327 · Pulmonary Hypertension Association RegistryRecrutando
🇺🇸 Estados Unidos
NCT06526468 · Chinese PE Multimodality Imaging Artificial Intelligence Stu…Recrutando
🇨🇳 China
NCT02061787 · the Application of Cardiopulmonary Exercise Testing in Asses…Recrutando
🇨🇳 China
NCT03388476 · Endtidal Carbon Dioxide for Earlier Detection of Pulmonary H…Por convite
🇩🇪 Alemanha

Outros ensaios clínicos

108 ensaios clínicos encontrados, 30 ativos.

Distribuição por fase
NCT07172334 · What is the Role of the Exposome in Pulmonary HypertensionEm breve
🇫🇷 França
NCT07644377 · Discontinuation Versus Continuation of Riociguat Monotherapy…Em breve
PHASE3🇫🇷 França
NCT07758179 · Continuous Remote Haemodynamic Monitoring With CardioMEMS™ F…Em breve
NCT07667829 · Vasopressor Agents in Pulmonary Hypertension CrisisEm breve
NA🇨🇳 China
NCT05629052 · TrEatment Approach in the Multimodal Era RegistryAtivo
🇧🇷 Brasil · 🇦🇷 Argentina · 🇦🇹 Áustria +17
NCT03102294 · Inspiratory Muscle Training in Pulmonary HypertensionConcluído
NA🇧🇷 Brasil
NCT02656238 · New International CTEPH DatabaseConcluído
🇧🇷 Brasil · 🇦🇺 Austrália · 🇦🇹 Áustria +19
NCT07704086 · Prehabilitation for Patients Undergoing Elective Cardiac Sur…Concluído
NA🇪🇸 Espanha
NCT06384534 · Exercise Performance on Ambient Air vs. Low-Flow Oxygen Ther…Concluído
NA🇨🇭 Suíça
NCT05179356 · Dapagliflozin in Pulmonary Arterial HypertensionConcluído
PHASE2🇩🇰 Dinamarca
NCT05568927 · Validation of SEARCH, a Novel Hierarchical Algorithm to Defi…Concluído
🇺🇸 Estados Unidos
NCT04663230 · Right Atrial Fibrosis in Pulmonary HypertensionConcluído
🇩🇪 Alemanha
NCT04730037 · Clinical Trial to Investigate Safety and Efficacy of Edoxaba…Concluído
PHASE3🇯🇵 Japão
NCT04773028 · The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Deve…Concluído
Turkey (Türkiye)
NCT03729544 · Computerized Decision Support to Increase Detection of Chron…Concluído
NA🇺🇸 Estados Unidos
NCT03953560 · Symptom-related Screening for Early Detection of CTEPH.Concluído
NA🇪🇸 Espanha
NCT03786367 · Dyspnea in Chronic Thromboembolic Pulmonary HypertensionConcluído
🇨🇦 Canadá
NCT03719027 · Prevalence of Chronic Thromboembolic Pulmonary Hypertension …Concluído
NA🇫🇷 França
NCT03422328 · A Clinical Study to Investigate the Long-term Safety of the …Concluído
PHASE3Belarus · 🇧🇪 Bélgica · 🇫🇷 França +4
NCT03245268 · International BPA RegistryConcluído
🇦🇹 Áustria · 🇧🇪 Bélgica · 🇨🇿 Tchéquia +7
NCT03757481 · Long-term Outcome After Heparin and Edoxaban Versus Heparin …Concluído
NA🇫🇷 França
NCT03198910 · Retrospective Data Analysis of Data From the Zurich PH Regis…Concluído
🇨🇭 Suíça
NCT03199131 · The Right Ventricle in Chronic Pressure Overload: Identifyin…Concluído
NA🇫🇷 França
NCT03074539 · Sleep-Disordered Breathing in Chronic Thromboembolic Pulmona…Concluído
NA🇦🇹 Áustria
NCT02555137 · Early Non-invasive Detection of CTEPH After Pulmonary Emboli…Concluído
🇧🇪 Bélgica · 🇳🇱 Países Baixos · 🇵🇱 Polônia
NCT02634203 · Riociguat Versus Balloon Pulmonary Angioplasty in Non-operab…Concluído
NA🇫🇷 França
NCT02429284 · U.S. CTEPH RegistryConcluído
🇺🇸 Estados Unidos
NCT02060721 · Clinical Study to Assess the Safety, Tolerability and Effica…Concluído
PHASE2🇧🇪 Bélgica · 🇨🇳 China · 🇨🇿 Tchéquia +12
NCT02565030 · Chronic Thrombo-embolic Pulmonary Hypertension: Classificati…Concluído
🇬🇧 Reino Unido
NCT05861479 · Prognostic Value of Estimated Plasma Volume in Pulmonary Hyp…Concluído
NCT02021292 · Clinical Study to Assess the Efficacy, Safety and Tolerabili…Concluído
PHASE2🇧🇪 Bélgica · 🇨🇳 China · 🇨🇿 Tchéquia +13
NCT02094001 · Pilot Study to Evaluate Right Ventricular Function With Rioc…Concluído
PHASE2🇨🇦 Canadá
NCT02111980 · RF Surgical Sponge-Detecting System on the Function of Pacem…Concluído
NA🇺🇸 Estados Unidos
NCT02114047 · Pulmonary Perfusion Heterogeneity in Patients With CTEPH Usi…Concluído
🇺🇸 Estados Unidos
NCT01884012 · Effect of Long-term Oxygen Therapy on Exercise Capacity and …Concluído
PHASE3🇨🇭 Suíça
NCT01748474 · Effect of Short-term Oxygen During CPET in Pulmonary Hyperte…Concluído
PHASE2🇨🇭 Suíça
NCT01393327 · Feasibility and Influence of Exercise Therapy on Oxygen Upta…Concluído
NA🇩🇪 Alemanha
NCT01416636 · Efficacy and Tolerability of Subcutaneously Administered Tre…Concluído
PHASE3🇦🇹 Áustria · 🇨🇿 Tchéquia · 🇩🇪 Alemanha +1
NCT00747045 · Lung Protective Ventilation in Pulmonary Thromboendarterecto…Concluído
NA🇺🇸 Estados Unidos
NCT00657722 · Identification of Criteria of the Success of the Endarterect…Concluído
NA🇫🇷 França
NCT00313222 · Bosentan Effects in Inoperable Forms of Chronic Thromboembol…Concluído
PHASE3
NCT06209710 · Balloon Pulmonary Angioplasty vs. Combined Approach With Pul…UNKNOWN
PHASE2, PHASE3Serbia
NCT06060366 · Impact of Pulmonary Endarterectomy on Sleep-Related Breathin…UNKNOWN
Turkey (Türkiye)
NCT06003244 · High Altitude (HA) Residents With Pulmonary Vascular Disease…UNKNOWN
NA🇨🇭 Suíça
NCT06092424 · High Altitude (HA) Residents With Pulmonary Vascular Disesea…UNKNOWN
NA🇨🇭 Suíça
NCT06072417 · HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea…UNKNOWN
NA🇨🇭 Suíça
NCT05996302 · HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Se…UNKNOWN
NA🇨🇭 Suíça
NCT06084559 · HA Residents With PVD, Pulmonary Artery Pressure (PAP) Asses…UNKNOWN
NA🇨🇭 Suíça
NCT05133713 · Ventilation and Perfusion Scan in Pulmonary Embolism Followi…UNKNOWN
🇺🇸 Estados Unidos
NCT04444973 · RV Conductance Catheter Assessment During Balloon Pulmonary …UNKNOWN
🇬🇧 Reino Unido
NCT04777448 · Optimized Management After Balloon Pulmonary Angioplasty in …UNKNOWN
NA
NCT04052243 · Hemodynamic Effects of BPA at Rest and During Exercise in CT…UNKNOWN
NA🇩🇰 Dinamarca · 🇯🇵 Japão · 🇵🇱 Polônia
NCT05480137 · OCT Evaluates the Effects of CTEPH Treated by Scoring Balloo…UNKNOWN
NA🇨🇳 China
NCT04881214 · COVID-19 Pneumonia: Pulmonary Physiology, Health-related Qua…UNKNOWN
NA🇨🇭 Suíça
NCT04326777 · Clinical Study of Balloon Pulmonary Angioplasty for Patients…UNKNOWN
NA🇨🇳 China
NCT04081012 · N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Ch…UNKNOWN
NA🇲🇽 México
NCT03806907 · Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmo…UNKNOWN
NCT03470207 · The Prospective Risk Factor Evaluation & Discovery In CTEPH …UNKNOWN
NA🇺🇸 Estados Unidos
NCT04007653 · Long-term Outcome After Edoxaban Versus Vitamin K Antagonist…UNKNOWN
🇳🇱 Países Baixos
NCT03795740 · Pulmonary Endarterectomy Guided by CT Scanning for Patients …UNKNOWN
NA🇨🇳 China
NCT03349164 · Registry of Patients With Chronic Thromboembolic Pulmonary H…UNKNOWN
Russia
NCT04681014 · CTEPH in Patients With Prior Pulmonary Embolism and Risk Sco…UNKNOWN
🇮🇹 Itália
NCT02660463 · Prospective Registry to Evaluate the Effective Incidence of …UNKNOWN
🇩🇪 Alemanha
NCT02745106 · Interventional Treatment of Residual Pulmonary Hypertension …UNKNOWN
PHASE2Russia
NCT02426203 · 3D Echocardiographic Assessment of RV Function in Patients U…UNKNOWN
NCT03195543 · Assessment of Blood Coagulation Disorders in Patients With P…UNKNOWN
Greece
NCT02268630 · Long Term Outcomes of Venous ThromboembolismUNKNOWN
🇳🇴 Noruega
NCT03579862 · Identification of Heritable CTEPHUNKNOWN
🇺🇸 Estados Unidos
NCT02964390 · Balloon Pulmonary Angioplasty in Non-operable CTEPH PatientsUNKNOWN
NA🇵🇱 Polônia
NCT01163422 · Right Ventricular Resynchronization TherapyUNKNOWN
NA🇳🇱 Países Baixos
NCT01417338 · Registry for Pulmonary Hypertension in ChinaUNKNOWN
🇨🇳 China
NCT01672203 · Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incide…UNKNOWN
🇩🇪 Alemanha
NCT00477724 · Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic…UNKNOWN
NA🇩🇪 Alemanha
NCT00348803 · Gene Mutations in Secondary Pulmonary HypertensionUNKNOWN
🇦🇹 Áustria
NCT03689244 · A Study to Find Out if Selexipag is Effective and Safe in Pa…Encerrado
PHASE3🇧🇷 Brasil · 🇦🇷 Argentina · 🇦🇺 Austrália +28
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Ensaio randomizado
Timeline de publicações
2.741 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 2.741

#1

A Phase 2, Randomized, Clinical Trial of Inhaled Nitric Oxide for Acute Severe Right Heart Failure With Pulmonary Hypertension (PHiNO Study).

Circulation journal : official journal of the Japanese Circulation Society2026 Mar 21

Acute right heart failure (RHF) is life threatening in patients with pulmonary hypertension (PH). This study investigated the efficacy and safety of inhaled nitric oxide (iNO; INOflo®for inhalation 800 ppm), a rapid pulmonary vasodilator, in patients with acute severe RHF due to PH. In this Phase 2 randomized controlled trial, 30 patients with acute severe RHF due to PH (pulmonary arterial hypertension or chronic thromboembolic PH) were randomized 1 : 1 to either an iNO or control group (which did not receive iNO). The primary endpoint was the change in pulmonary vascular resistance (PVR) from baseline to 30 min after either iNO initiation or patient registration and assignment (control group), which differed significantly between the iNO and control groups (mean [±SD] -2.41±2.47 vs. 0.8±1.03 Wood units, respectively; between group difference -3.21 [95% confidence interval -4.633, -1.785] Wood units). Serum B-type natriuretic peptide (BNP) levels and inferior vena cava diameter (secondary endpoints) decreased significantly in the iNO group over the 7-day study period. No serious adverse events, including methemoglobinemia, were observed. iNO significantly reduced PVR in patients with acute severe RHF due to PH, without serious adverse events. Serum BNP levels and inferior vena cava diameter improved in the iNO group. These findings suggest that iNO is a promising acute treatment option for RHF due to PH.

#2

Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.

Circulation reports2026 Mar 10

Patients with myeloproliferative neoplasms (MPN) are known to complicate pulmonary hypertension (PH). Half of patients with MPN-associated PH have chronic thromboembolic PH (CTEPH); however, the prevalence, clinical characteristics, and treatment response remain unclear. Nagoya PH registry database was retrospectively analyzed. Of 129 CTEPH patients, 82 were included. Clinical characteristics and treatment response were compared between CTEPH patients with MPN (MPN group) and those without MPN (non-MPN group). As the treatment course at Nagoya University Hospital, medical treatment was initiated before performing balloon pulmonary angioplasty (BPA)/pulmonary endarterectomy (PEA). Right heart catheterization was performed at pre-medication, post-medication, and post-BPA/PEA. Seven patients had concomitant MPN as the underlying cause for CTEPH, accounting for 5.4% (7/129) of CTEPH cases. Baseline clinical characteristics were comparable between the MPN and non-MPN groups. No significant difference was observed in ∆pulmonary vascular resistance (PVR) from baseline to post-medical treatment (-3.59 WU in the MPN group vs. -3.80 WU in the non-MPN group; P=0.67) and baseline to post-BPA/PEA (-6.92 WU in the MPN group vs. -7.60 WU in the non-MPN group; P=0.35). As hemodynamic responses to treatment in CTEPH patients with MPN were comparable with those without MPN, their prognosis may improve with multimodal CTEPH treatment similar to non-MPN cases.

#3

Residual physiological abnormalities after pulmonary endarterectomy and balloon pulmonary angioplasty in CTEPH.

PloS one2026

Pulmonary endarterectomy (PEA) is the first-line treatment for chronic thromboembolic pulmonary hypertension (CTEPH), while balloon pulmonary angioplasty (BPA) is an established alternative for inoperable patients. Although both interventions improve resting pulmonary hemodynamics, the extent of long-term physiological recovery during exercise and the persistence of functional limitations remain incompletely characterized. Prospective single-center registry (2017-2023) including 14 patients completing BPA (71 sessions) and 15 undergoing PEA, with median follow-up of 50 months (IQR 36-61). Clinical assessment included resting hemodynamics, invasive exercise right heart catheterization to derive the exercise slope of the mean pulmonary arterial pressure to cardiac output relashionship (mPAP/CO slope), and health-related quality of life (HRQOL) evaluated using the SF-36 questionnaire. Analyses were descriptive and focused on within-pathway changes over time. Both BPA and PEA significantly reduced mPAP (44.8 ± 12.4 → 26.1 ± 9.3 mmHg; 42.1 ± 12.9 → 22.6 ± 5.4 mmHg, both p < 0.001) and pulmonary vascular resistance (9.8 ± 4.6 → 3.0 ± 1.3 WU; 9.0 ± 5.4 → 2.9 ± 1.9 WU, both p < 0.001) at long term follow-up. Despite sustained improvements in resting hemodynamics, abnormal exercise pulmonary vascular responses persisted, with mean mPAP/CO slopes of 7.0 ± 5.6 mmHg/L/min after BPA and 4.0 ± 2.3 mmHg/L/min after PEA. Physical HRQOL remained impaired at long-term follow-up, with Physical Component Summary (PCS) scores below population norms in both pathways (44.4 ± 12.7 after BPA and 44.5 ± 7.3 after PEA). BPA and PEA provide durable improvements in resting pulmonary hemodynamics; however, incomplete physiological recovery is common, with persistent exercise abnormalities and reduced physical quality of life at long-term follow-up.

#4

Clinical Profile and Admission Outcomes of Patients With Acute Pulmonary Embolism at a Resource-Constrained Hospital in Ghana: A Retrospective Pilot Study.

Health science reports2026 Mar

Pulmonary embolism is a cardiovascular disease associated with significant morbidity and mortality. There is a paucity of literature regarding this condition from the Ghanaian perspective. This study aimed at evaluating the clinical profile and admission outcomes of patients with acute pulmonary embolism at the Methodist Hospital, Wenchi, Ghana. A retrospective pilot study was conducted by analyzing medical records of patients diagnosed with acute pulmonary embolism from September 2023 to March 2025. Data on demographics, clinical manifestations, risk factors, investigations, treatment, and outcomes of admission were collected. Out of 17 patients enrolled in the study, 11 (64.7%) were females. The mean age was 58.8 ± 13.0 years. The commonest risk factors were age > 65 years (n = 6), immobilization (n = 5), obesity (n = 4), and recent surgery (n = 3). Hypertension and diabetes mellitus were the predominant comorbidities. Dyspnea (76.5%, n = 13) and chest pain (n = 5) were the most frequent presenting symptoms while tachypnea (70.6%, n = 12), tachycardia (70.6%, n = 12), and hypoxia (52.9%, n = 9) were the commonest clinical signs. Three patients had hemodynamic instability. Pretest probability assessment was infrequently performed (n = 7). Sinus tachycardia (76.5%, n = 13) was the predominant electrocardiographic abnormality. The majority (58.8%, n = 10) had intermediate-risk pulmonary embolism whereas 3 patients were classified as having high-risk pulmonary embolism. Two in-hospital mortalities were recorded. Clinical features and predisposing factors were largely similar to those described in the literature. Also, pretest probability assessment was underutilized. In-hospital mortality rate (11.8%) was relatively high. Large-scale, multicenter prospective studies are recommended to assess long-term complications of acute pulmonary embolism such as recurrence and chronic thromboembolic pulmonary hypertension.

#5

Notch signaling enhances PASMC proliferation and vascular remodeling in CTEPH.

Open life sciences2026 Jan

The Notch signaling pathway is implicated in pulmonary vascular remodeling (PVR) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH). This study investigated the role of Notch signaling in PVR using a rat model of CTEPH and performed measurements including Right Ventricular Systolic Pressure (RVSP), Mean Pulmonary Arterial Pressure (MPAP), and histological analysis of pulmonary small arteries. Western blot analysis revealed elevated levels of Notch1, Notch3, Jagged1, and Hes1 proteins in CTEPH rats. Furthermore, the Notch pathway proteins (Notch1, Notch3, Jagged1, and Hes1) were even more elevated in the CTEPH + VPA group. In contrast, protein levels were reduced in the CTEPH + DAPT (a γ-secretase inhibitor) group. The medial wall thickness percentage (MWT%) and markers of smooth muscle cell proliferation, including PCNA and α-SMA, were significantly increased in the CTEPH and CTEPH + VPA groups and decreased after DAPT treatment. These findings suggest that activation of the Notch signaling pathway promotes the proliferation of Pulmonary Artery Smooth Muscle Cells (PASMCs), contributing to PVR in CTEPH. Inhibition of Notch signaling with DAPT mitigated vascular remodeling, suggesting a potential therapeutic target for CTEPH.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2.276 artigos no totalmostrando 196

2026

Long term effects of medical therapy pre- and post- pulmonary endarterectomy - insights from the UK CURATE registry.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2026

A Phase 2, Randomized, Clinical Trial of Inhaled Nitric Oxide for Acute Severe Right Heart Failure With Pulmonary Hypertension (PHiNO Study).

Circulation journal : official journal of the Japanese Circulation Society
2026

Carbon dioxide angiography-guided balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension with iodinated contrast allergy.

Cardiovascular intervention and therapeutics
2026

[Sleep disorders dynamics in patients with chronic thromboembolic pulmonary hypertension after surgical treatment].

Terapevticheskii arkhiv
2026

Surgical thrombus removal in acute pulmonary embolism. Where do we stand today?

The Journal of cardiovascular surgery
2026

Cone-Beam Computed Tomography Scan and Three-Dimensional Roadmap for Balloon Pulmonary Angioplasty.

The Kurume medical journal
2026

Provider networks for pulmonary hypertension in Massachusetts: implications for improving referrals to expert care.

Annals of the American Thoracic Society
2026

Critical Care Management of the Patient with Pulmonary Hypertension.

Journal of intensive care medicine
2026

Exercise for treatment and prevention of post-pulmonary embolism syndrome: A review.

Vascular medicine (London, England)
2026

Deep learning-based identification of chronic pulmonary embolism on CTPA: a regional lung analysis using multiplanar MIP images.

European radiology experimental
2026

Animal models of chronic thromboembolic pulmonary hypertension.

Animal models and experimental medicine
2026

Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: a comprehensive systematic review and meta-analysis.

European journal of internal medicine
2026

Respond to "comments and opinions regarding "High antiphospholipid antibody titers and outcomes of pulmonary endarterectomy: a single-center retrospective observational cohort study" by Miard et al.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2026

[Use of modified balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension: a retrospective study from a single center].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2026

Application of murine hindlimb deep vein thrombosis model to assess temporal evolution and hemodynamic sequelae of pulmonary embolism.

Biochemical and biophysical research communications
2026

Chronic thromboembolic pulmonary hypertension: insights from the 100 most cited papers: a bibliometric perspective.

Journal of thoracic disease
2026

Role of PKM2 Tetramer in Modulating Endothelial Mitochondrial Dysfunction in a Rat Model of Chronic Thromboembolic Pulmonary Hypertension.

Physiological research
2026

Perioperative Use of Pulmonary Artery Catheter in a Patient With Severe Chronic Thromboembolic Pulmonary Hypertension Undergoing Major Gynecological Surgery: A Case Report.

Cureus
2026

Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.

Circulation reports
2026

Smoking exposure on diagnosis and survival of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from REHAP registry.

Pulmonology
2026

Residual physiological abnormalities after pulmonary endarterectomy and balloon pulmonary angioplasty in CTEPH.

PloS one
2026

Clinical Profile and Admission Outcomes of Patients With Acute Pulmonary Embolism at a Resource-Constrained Hospital in Ghana: A Retrospective Pilot Study.

Health science reports
2025

Distinct endothelial cells in chronic thromboembolic pulmonary hypertension.

NPJ cardiovascular health
2026

In vivo targeting of fibroblast activation in chronic thromboembolic pulmonary hypertension: Ready for pulmonary prime time?

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
2026

Notch signaling enhances PASMC proliferation and vascular remodeling in CTEPH.

Open life sciences
2026

Post-pulmonary embolism syndrome: a practical narrative review.

Revista clinica espanola
2026

[Rehabilitation after pulmonary Embolism].

Die Rehabilitation
2026

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Journal of the American College of Cardiology
2026

Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.

Pulmonary circulation
2026

Current perspectives on imaging modalities in the diagnosis and management of pulmonary hypertension.

Respiratory investigation
2026

A diagnostic challenge: unveiling chronic thromboembolic pulmonary hypertension in the absence of visible thrombi: a case report.

European heart journal. Case reports
2026

Diagnostic Performance of Quantitative Lung Perfusion SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study.

Diagnostics (Basel, Switzerland)
2026

Pulmonary thromboendarterectomy and cavotomy of calcified superior vena cava.

Turk gogus kalp damar cerrahisi dergisi
2026

Echocardiographic Assessment After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Which Parameters Reflect Improved Right Ventricular Function?

Pulmonary circulation
2026

Chronic Thromboembolic Pulmonary Hypertension and Elevated Pulmonary Arterial Wedge Pressure: No Fear of BPA!

Chest
2026

Right Atrial Function and Tricuspid Regurgitation in Chronic Thromboembolic Pulmonary Hypertension.

Echocardiography (Mount Kisco, N.Y.)
2026

Expanding the boundaries of PTE: successful integration with multiple major cardiac procedures.

Journal of surgical case reports
2026

Obstructive sleep apnea and echocardiographic indicators of elevated pulmonary hypertension probability after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Sleep medicine
2026

Temporal Trends in Age Profile and Safety of Balloon Pulmonary Angioplasty for CTEPH.

JACC. Asia
2026

Impact of Preoperative Hemodynamic Values on Development of Reperfusion Edema After Pulmonary Endarterectomy.

Pulmonary circulation
2026

Vascular Obstruction Scoring on Dual-energy CT, Cone-beam CT and Digital Subtraction Angiography: Correlation with Invasive Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension.

Academic radiology
2026

microRNAs as epigenetic biomarkers for CTEPH: a case-control study towards personalised medicine.

ERJ open research
2026

How long does chronic thromboembolic pulmonary hypertension take to develop? Two cases of post-thrombotic complete occlusion of the left pulmonary artery.

Polish archives of internal medicine
2026

Transmembrane Protein 100 Expression on Endothelial Cells Vascularizing Thrombi in Chronic Thromboembolic Pulmonary Hypertension Modulates TGFβ1-ALK1 Signaling During Angiogenesis.

Pulmonary circulation
2025

A swine model of severe chronic thromboembolic pulmonary hypertension induced by repeated pulmonary artery long suture injection.

Frontiers in cardiovascular medicine
2026

Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease.

Pulmonary medicine
2026

Pulmonary endarterectomy in antiphospholipid syndrome: a retrospective analysis from the Saudi pulmonary hypertension registry.

Frontiers in medicine
2026

Role and interpretation of lung scintigraphy for long-term management of pulmonary embolism.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
2025

Efficacy and safety of specific treatment combined with SGLT2-i in pulmonary hypertension.

Frontiers in cardiovascular medicine
2025

Effects of balloon pulmonary angioplasty on cardiac and pulmonary functions and complications in patients with chronic thromboembolic pulmonary hypertension.

Frontiers in medicine
2026

Post-Pulmonary Embolism Syndrome: New Phenotypes Come into Focus.

Journal of clinical medicine
2026

Pulmonary Embolism in Antiphospholipid Syndrome (APS)-Where Are We and Where Are We Going?

International journal of molecular sciences
2026

Genetic and Clinical Determinants of Chronic Thromboembolic Pulmonary Hypertension: The Role of PAI-1 Polymorphism.

International journal of molecular sciences
2026

Perfusion-only Q-SPECT as a rule-out tool for CTEPH in resource-limited settings: a feasibility study on reducing unnecessary referrals to tertiary centers.

BMC pulmonary medicine
2026

Exercise tolerance in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.

Heart &amp; lung : the journal of critical care
2026

sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertension.

The European respiratory journal
2026

Development and Characterization of a Novel Chronic Thromboembolic Pulmonary Hypertension Rat Model: Identifying Sell-Podxl as Potential Regulators.

Hypertension (Dallas, Tex. : 1979)
2026

Stress testing in the diagnosis and early screening of chronic thromboembolic pulmonary disease with and without pulmonary hypertension.

European journal of clinical investigation
2026

Role of hsa-miR-122-5p in chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease: Targeting PIK3CG in the PI3K/Akt signaling pathway.

Medicine
2026

Management of airway hemorrhage with endobronchial valve in patients undergoing pulmonary endarterectomy- an expert center experience: a case report.

BMC anesthesiology
2026

Anticoagulation in chronic thromboembolic pulmonary hypertension: an updated systematic review and meta-analysis.

Internal and emergency medicine
2026

Artificial intelligence in lung scintigraphy.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
2026

Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension.

Pulmonary circulation
2026

Lung transplantation for chronic thromboembolic pulmonary hypertension.

JHLT open
2026

Preoperative Right Ventricle-to-Pulmonary Artery Coupling Correlates With Intensive Care Length of Stay After Pulmonary Endarterectomy.

Journal of cardiothoracic and vascular anesthesia
2026

Pulmonary Venous Atresia as a Mimicker of Chronic Thromboembolic Pulmonary Disease: Diagnostic Utility of Ventilation/Perfusion Scanning.

Journal of nuclear medicine technology
2026

What is the difference between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension on phase-resolved functional lung MRI? A cross-sectional observational study.

European radiology
2026

Echocardiographic Analysis of Tricuspid Regurgitation and Other Hemodynamic Factors in Relation to Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Echocardiography (Mount Kisco, N.Y.)
2025

Chronic Thromboembolic Pulmonary Hypertension Incidence, Post-pulmonary Embolism Syndrome and Possible Role of Transcatheter Therapy in Prevention.

Interventional cardiology (London, England)
2025

Current Perspectives on Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Journal of clinical medicine
2025

Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126.

Diagnostics (Basel, Switzerland)
2025

Lung Tissue RNA Sequencing Shows Dysregulation of the Bronchial Epithelium in a Rat Model of Chronic Thromboembolic Pulmonary Hypertension.

Bulletin of experimental biology and medicine
2026

Is Septic Revision Knee Arthroplasty Associated with Higher Thromboembolic Events? A Matched Cohort Study.

The Journal of arthroplasty
2026

Pulmonary tumour thrombotic microangiopathy or chronic thromboembolic pulmonary hypertension?-diagnosed by pulmonary wedge aspiration cytology using a Swan-Ganz catheter: a case report.

European heart journal. Case reports
2026

Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension.

Thorax
2026

Management of Chronic Thromboembolic Pulmonary Hypertension Before and After Pulmonary Thromboendarterectomy.

Chest
2026

[Balloon pulmonary angioplasty in Gottsegen National Cardiovascular Center - results of the first 2 years].

Orvosi hetilap
2026

Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study.

BMC pulmonary medicine
2025

Severe pulmonary hypertension associated with unilateral pulmonary artery hypoplasia: A case report.

ARYA atherosclerosis
2026

Splenectomy Increases CTEPH Risk and Modifies Clinical Features of Acute Pulmonary Embolism.

Pulmonary circulation
2025

Optimizing surgical management for pulmonary artery sarcoma: A 24-year single-center analysis.

JTCVS open
2025

Leveraging Vascular Over Ventricular Ratios in Observational Chronic Thromboembolic Pulmonary Hypertension and Acute Pulmonary Embolism Cohorts to Decode Clot Chronicity on Computed Tomography Angiography.

Pulmonary circulation
2025

Evaluation of Predisposing Factors and Coexisting Diseases in the Development of Chronic Thromboembolic Pulmonary Disease.

The clinical respiratory journal
2025

Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension.

Thrombosis journal
2026

Large-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: Rationale and design of the PERSEVERE randomized controlled trial.

American heart journal
2025

Follow-up algorithm for detecting chronic sequelae of pulmonary embolism: diagnostic performance and possible limitations.

Journal of thrombosis and haemostasis : JTH
2025

Diagnostic performance of lung perfusion SPECT/CT using perfusion defect and decrease criteria: a comparative study with CTPA in pulmonary thromboembolism.

Annals of nuclear medicine
2025

Minimally Invasive Pulmonary Thromboendarterectomy by a J-Shaped Upper Hemisternotomy.

Annals of thoracic surgery short reports
2025

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.

Seminars in interventional radiology
2025

Screening for an underlying myeloproliferative neoplasm in patients with chronic thromboembolic pulmonary hypertension.

Respiratory medicine and research
2026

Real-World Treatment Patterns and Burden of Chronic Thromboembolic Pulmonary Hypertension Patients across Consultation Settings in the USA.

Pulmonary therapy
2025

Pulmonary hemorrhage after pulmonary endarterectomy in a patient with chronic thromboembolic pulmonary hypertension: a case report.

The journal of extra-corporeal technology
2025

Combining pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a narrative review of hybrid therapy approaches.

ERJ open research
2026

[Analysis of follow-up and prognosis in pediatric rheumatic diseases associated with pulmonary embolism].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

From Patient-Specific Hemodynamic Modeling to Clinical Decision-Making in Chronic Thromboembolic Pulmonary Hypertension: Opportunities and Caveats.

Pulmonary circulation
2025

From Deep Hypothermia to Goal-Directed Perfusion: Contemporary Insights Into Perfusion Techniques for Pulmonary Endarterectomy, Including a Narrative Review and Perspectives.

Cureus
2025

Cerebral, Muscle and Blood Oxygenation in Patients with Pulmonary Vascular Disease Whilst Breathing Normobaric Hypoxia vs. Normoxia Before and After Sildenafil: Data from a Randomised Controlled Trial.

Journal of clinical medicine
2025

Sclerotherapy embolism: a novel etiology for chronic thromboembolic pulmonary disease.

BMC pulmonary medicine
2025

Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy.

Scientific reports
2025

Upfront combination therapy with sildenafil and ambrisentan in patients with chronic thromboembolic pulmonary hypertension.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
2025

Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.

ERJ open research
2025

Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.

ERJ open research
2025

Association of bioelectrical impedance phase angle with exercise tolerance in patients with chronic thromboembolic pulmonary hypertension.

Scientific reports
2025

8 F Catheter Percutaneous Mechanical Thrombectomy Plus Anticoagulation Versus Anticoagulation Alone in Intermediate-High Risk Acute Pulmonary Embolism: A Multicenter Real-World Study on Long-Term Complications, Right Heart Function, and Quality of Life.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions
2025

[Venous thromboembolism : therapeutic strategies].

Revue medicale suisse
2025

SPHK1-mediated M2 macrophage polarization drives TGF-β1-dependent thrombus fibrosis.

Frontiers in immunology
2025

Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Clinical and translational science
2026

Old clots, new questions - the anticoagulation saga continues in chronic thromboembolic pulmonary hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

[Chronic thromboembolic pulmonary hypertension - the hidden disease].

Orvosi hetilap
2025

Application and Challenges of Deep Learning in Pulmonary Vessels Segmentation of CTPA Images.

IEEE journal of biomedical and health informatics
2025

Efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension in patients with cancer comorbidity.

Kardiologia polska
2026

Comparative outcomes of ultrasound-assisted catheter-directed thrombolysis between patients with acute and acute-on-chronic pulmonary embolism.

Thrombosis research
2025

Why Is Pulmonary Endarterectomy Underused in Japan? Epidemiology, Genetics, and a Practical Operability Framework.

Pulmonary circulation
2025

Inflammation-Based Hematologic Indices as Prognostic Markers in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension: A Hypothesis-Generating Registry Study.

International journal of molecular sciences
2025

Genetic Analysis of Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Single-Center Observational Study.

Genes
2026

Results of the MACiTEPH study of macitentan for the treatment of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2026

Dual-energy computed tomography (CT) versus cone-beam computed tomography (CT) in chronic thromboembolic pulmonary hypertension: diagnostic accuracy compared with digital subtraction angiography.

Clinical radiology
2025

Enhancing methodological rigour in meta-analyses of renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

The European respiratory journal
2026

Quantifying right ventricular fibrosis burden in chronic thromboembolic pulmonary hypertension via fibroblast activation protein inhibitor single photon emission computed tomography/computed tomography: Correlation with echocardiographic parameters and balloon pulmonary angiography response.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
2025

The relationship between preoperative clinical, respiratory, and hemodynamic parameters and the surgical anatomical classification of thrombi in patients with chronic thromboembolic pulmonary hypertension.

BMC pulmonary medicine
2025

Cardiovascular MRI-based Biventricular Perfusion Assessment in Two Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary Thromboendarterectomy.

Radiology. Cardiothoracic imaging
2025

A scoping review of photon-counting detector computed tomography in cardiovascular imaging.

Diagnostic and interventional radiology (Ankara, Turkey)
2025

Circulating Pin1 Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Case-Control Study.

Pulmonary circulation
2025

Catheter-directed versus standard therapy in intermediate-high-risk pulmonary embolism: A retrospective cohort study.

Archives of cardiovascular diseases
2025

American Lung Association Pulmonary Hypertension Roundtable: Executive Summary.

Pulmonary circulation
2025

Proximal pulmonary artery wall shear stress derived from computational fluid dynamics: A noninvasive biomarker for CTEPH and perfusion mismatch.

Physiological reports
2026

In situ pulmonary arterial thrombosis in pulmonary arterial hypertension: Diagnostic differentiation, imaging criteria, and management-A narrative review with an institutional case-series snapshot.

Current problems in cardiology
2026

Pulmonary artery fresh floating thrombus in patients with chronic thromboembolic pulmonary hypertension on low-dose direct oral anticoagulants: A single-center angiographic observational study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Characteristics of ferritinophagy-related genes in chronic thromboembolic pulmonary hypertension, a study based on bioinformatics with machine learning model.

Respiratory medicine
2025

Magnetic resonance direct thrombus imaging to distinguish acute pulmonary embolism from chronic thromboembolic pulmonary hypertension: a case report.

European heart journal. Case reports
2025

The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy.

ERJ open research
2025

From Pathways to Patients: Contemporary Approaches to Pulmonary Hypertension.

Cardiology in review
2025

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA).

Circulation. Cardiovascular interventions
2025

Chronic thromboembolic pulmonary hypertension associated with venous thoracic outlet syndrome: a retrospective case series.

The European respiratory journal
2025

Increased lung [18F]-FDG uptake in chronic thromboembolic pulmonary hypertension with distal involvement.

The European respiratory journal
2025

The Predictive Value of Quantitative Analysis of SPECT V/Q Imaging for Postoperative Persistent/Recurrent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy.

Pulmonary circulation
2025

Emergency Pulmonary Thromboendarterectomy in Malignancy.

JACC. Case reports
2025

Causal Effect of Pulmonary Hypertension on Brain Structure: A Mendelian Randomization Study Combined With Brain Magnetic Resonance Imaging.

Cureus
2025

The expanding role of intraoperative transesophageal echocardiography in pulmonary endarterectomy for CTEPH.

Indian journal of thoracic and cardiovascular surgery
2025

Bridging to a delayed pulmonary endarterectomy in massive acute-on-chronic pulmonary thromboembolism: a case report.

Journal of cardiothoracic surgery
2025

A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension.

American journal of respiratory and critical care medicine
2025

Diagnosis model for assessing chronic thromboembolic pulmonary hypertension in high-altitude pulmonary embolism patients: a machine learning approach.

Frontiers in medicine
2025

Factors affecting patient outcomes in pulmonary artery thromboendarterectomy under deep hypothermic circulatory arrest and cardiopulmonary bypass support----a single center's experience.

BMC cardiovascular disorders
2025

Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy.

American journal of respiratory cell and molecular biology
2026

Impact of Elevated Pulmonary Arterial Wedge Pressure on Safety and Efficacy of Balloon Pulmonary Angioplasty in the Treatment of Chronic Thromboembolic Pulmonary Hypertension.

Chest
2025

Intravenous Treprostinil in Precapillary and Postcapillary Pulmonary Hypertension Due to Cardiac Amyloidosis and Aortic Stenosis.

JACC. Case reports
2026

Lung transplantation for chronic thromboembolic pulmonary hypertension (CTEPH): A treatment of last resort.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.

Pulmonary circulation
2025

The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension.

Journal of clinical medicine
2025

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension after bilateral lung transplantation.

JHLT open
2025

Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertension.

Journal of translational medicine
2025

Evaluation of gene and microRNA expression patterns in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as rare diseases.

Respiratory medicine
2026

Lung transplantation for chronic thromboembolic pulmonary hypertension-a case series.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

An Unusual Initial Manifestation of Pulmonary Embolism: Aseptic Cavitary Infarction With Pulmonary Hypertension-Case Report and Literature Review.

Respirology case reports
2025

Quantitative Evaluation of Lung Perfusion by Dynamic Chest Radiography in Chronic Thromboembolic Pulmonary Hypertension: Comparison With Lung Perfusion Scintigraphy.

Pulmonary circulation
2025

[Chronic Thromboembolic Pulmonary Hypertension].

Pneumologie (Stuttgart, Germany)
2025

[Innovations in the Field of Pulmonary Hypertension - Critical Assessment of the Results of the 7th World Symposium on Pulmonary Hypertension].

Pneumologie (Stuttgart, Germany)
2025

Use of direct anticoagulants in chronic thromboembolic pulmonary hypertension: An anatomopathological study of endarterectomy material.

International journal of cardiology
2025

The influence factors on the resolution of pulmonary embolism by CT pulmonary angiography.

Thrombosis journal
2025

Balloon Pulmonary Angioplasty Versus Riociguat in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Cardiology in review
2025

Long-Term Outcomes of Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis.

Journal of the Society for Cardiovascular Angiography &amp; Interventions
2026

Endothelin-1 overexpression in pulmonary endarterectomy specimens of CTEPH patients is associated with pulmonary hypertension development.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Tricuspid Regurgitation and Pulmonary Haemodynamics After Pulmonary Endarterectomy.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
2025

Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Review of Prevalence, Clinical Phenotype, and Surgical Outcomes.

Biomedicines
2025

A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism.

Scientific reports
2025

Practical guide to management after an acute pulmonary embolism.

BMJ open respiratory research
2025

Imaging in chronic thromboembolic pulmonary hypertension: review of the current literature.

Diagnostic and interventional radiology (Ankara, Turkey)
2026

Gas exchange dynamics and responses to exercise in chronic thromboembolic pulmonary hypertension.

Respiratory physiology &amp; neurobiology
2025

Effectiveness and Safety of Reduced-Dose and Slow-Infusion Intravenous Tissue-Type Plasminogen Activator Regimen in Patients with Acute Pulmonary Embolism at Intermediate-High Risk.

Anatolian journal of cardiology
2025

A Rare Case of Chronic Thromboembolic Pulmonary Hypertension in an Elderly With Atrial Septal Defect and Eisenmenger Syndrome.

Cureus
2025

Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide study.

ERJ open research
2025

Effects of Web-Based Symptom Monitoring Program on Symptom Interference, Physical Activity, and Emergency Department Readmissions in Patients With Pre-Capillary Pulmonary Hypertension: Randomized Controlled Trial.

Journal of medical Internet research
2025

Pulmonary thrombectomy and extracorporeal membrane oxygenation: a case study.

The journal of extra-corporeal technology
2025

Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH).

Diagnostics (Basel, Switzerland)
2025

Riociguat for CTEPH: A retrospective cohort study from a single reference center in Brazil.

Clinics (Sao Paulo, Brazil)
2025

Spatial heterogeneity and distribution of CT-Based pulmonary vascular volumes in chronic thromboembolic pulmonary hypertension.

European journal of radiology
2025

Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.

Open heart
2026

CT scoring system to defined thrombus distribution in chronic thromboembolic pulmonary hypertension.

The British journal of radiology
2025

Chronic Thromboembolic Pulmonary Hypertension in Latvia: Epidemiological Insights and Diagnostic Challenges From 2024.

Pulmonary circulation
2025

High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension.

Pulmonary circulation
2025

Sequential Combination of Balloon Pulmonary Angioplasty for Distal Lesions in the Left Pulmonary Artery Followed by Pulmonary Endarterectomy for Central Lesions in the Right Pulmonary Artery: A Case Report.

Pulmonary circulation
2025

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Technical challenges and controversies.

JHLT open
2026

Klippel-Trenaunay Syndrome with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Pneumologie (Stuttgart, Germany)
2025

Assessment of Right Ventricular Pressure in Chronic Thromboembolic Pulmonary Hypertension: Comparison of Diagnostic Modalities and Balloon Pulmonary Angioplasty Outcomes.

Diagnostics (Basel, Switzerland)
2025

The Effect of Eccentric Cycling on Cerebral and Muscle Tissue Oxygenation in Patients with Pulmonary Hypertension and Healthy Individuals: A Randomized Controlled Crossover Trial.

Journal of clinical medicine
2025

Echo-Doppler Predictors of Residual Pulmonary Hypertension After Pulmonary Thromboendarterectomy.

Journal of clinical medicine
2025

Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions
2026

Utility of machine learning for predicting severe chronic thromboembolic pulmonary hypertension based on CT metrics in a surgical cohort.

European radiology
2026

Combined multimodal therapy in high-risk patients with chronic thromboembolic pulmonary hypertension and both distal and proximal lesions: A prospective observational cohort study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Hemodynamics assessment using 4D flow CMR before and after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a retrospective observational study.

BMC cardiovascular disorders
2025

Detectability of subsegmental lesions in patients with inoperable CTEPH: Comparison between ultra-high-resolution vs. conventional CT.

JHLT open
2025

Pathogenesis, Diagnosis, and Management of Chronic Thromboembolic Pulmonary Hypertension.

Cardiac electrophysiology clinics
2025

Management of Complications of Balloon Pulmonary Angioplasty.

Cardiac electrophysiology clinics
2025

Outpatient Follow-up of Pulmonary Embolism: Putting It all Together.

Cardiac electrophysiology clinics
2025

Evolving Role and Clinical Evidence in the Global Practice of Balloon Pulmonary Angioplasty.

Cardiac electrophysiology clinics
Ver todos os 2.276 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Hipertensão pulmonar tromboembólica crônica.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Hipertensão pulmonar tromboembólica crônica e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Protocolo oficial relacionado (Ministério da Saúde)PCDT: Hipertensão Arterial Pulmonar

Existe um documento oficial para "Hipertensão Arterial Pulmonar". Ele pode não cobrir esta forma específica da doença — confira no texto do protocolo antes de contar com ele.

Respostas geradas por IA a partir das fontes citadas

A condição é causada pelo acúmulo e permanência de coágulos organizados que cicatrizam e obstruem as artérias dos pulmões. Isso eleva a resistência para a passagem do sangue, resultando em hipertensão pulmonar e sobrecarga no ventrículo direito.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:70591
    Orphanet
  2. GARD:13124
    GARD (NIH)
  3. Q1958249
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Hipertensão pulmonar tromboembólica crônica. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/hipertensao-pulmonar-tromboembolica-cronica

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Hipertensão pulmonar tromboembólica crônica

ORPHA:70591 · MONDO:0013024
Prevalência
Unknown
Herança
Not applicable
CID-10
I26.0 · Embolia pulmonar com menção de cor pulmonale agudo
CID-11
Ensaios
30 ativos
Início
Adolescent, Adult, Elderly
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C2363973
Repurposing
141 candidatos
acebutolol — adrenergic receptor antagonist
alacepril — angiotensin converting enzyme inhibitor
aliskiren-hemifumarate — renin inhibitor
+17 outros
EuropePMC
Wikidata
Papers 10a
Evidência
🥇 Ensaio rand.

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Genética mendeliana
fonte: OMIM
Dado público estruturado
fonte: Wikidata
Medicamentos aprovados FDA
fonte: FDA OpenFDA
Rara